|
RBM45 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.202100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.268090E-02 |
| Normal-vs-Stage2 |
4.058200E-02 |
| Normal-vs-Stage3 |
7.379700E-04 |
| Normal-vs-Stage4 |
6.594100E-02 |
| Stage1-vs-Stage2 |
5.729600E-01 |
| Stage1-vs-Stage3 |
4.735700E-02 |
| Stage1-vs-Stage4 |
9.031800E-01 |
| Stage2-vs-Stage3 |
5.342200E-01 |
| Stage2-vs-Stage4 |
5.522000E-01 |
| Stage3-vs-Stage4 |
1.231420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.879830E-03 |
| Normal-vs-AfricanAmerican |
2.307400E-01 |
| Normal-vs-Asian |
2.629000E-01 |
| Caucasian-vs-AfricanAmerican |
1.977400E-01 |
| Caucasian-vs-Asian |
9.471000E-01 |
| AfricanAmerican-vs-Asian |
5.703600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.167300E-04 |
| Normal-vs-Female |
1.406980E-01 |
| Male-vs-Female |
3.261100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.041880E-02 |
| Normal-vs-Age(41-60Yrs) |
6.300300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.171820E-02 |
| Normal-vs-Age(81-100Yrs) |
7.556300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.721800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.767970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.188200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.426800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.228800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.733800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.441600E-01 |
| Normal-vs-Grade 2 |
9.972200E-02 |
| Normal-vs-Grade 3 |
4.434800E-04 |
| Normal-vs-Grade 4 |
7.355800E-04 |
| Grade 1-vs-Grade 2 |
5.405800E-01 |
| Grade 1-vs-Grade 3 |
1.111990E-01 |
| Grade 1-vs-Grade 4 |
7.352500E-02 |
| Grade 2-vs-Grade 3 |
1.422340E-02 |
| Grade 2-vs-Grade 4 |
1.123560E-02 |
| Grade 3-vs-Grade 4 |
3.649000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.666760E-01 |
| Normal-vs-ccB subtype |
3.91339999999962E-05 |
| ccA subtype-vs-ccB subtype |
6.20660000000273E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.118100E-02 |
| Normal-vs-N1 |
8.441800E-02 |
| N0-vs-N1 |
5.211000E-01 |
|
|
